Vessel tortuosity and brain tumor malignancy: a blinded study.

[1]  Y. Katayama,et al.  Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas , 2006, Brain Tumor Pathology.

[2]  Stephen R. Aylward,et al.  Analyzing attributes of vessel populations , 2005, Medical Image Anal..

[3]  Elizabeth Bullitt,et al.  Correlation of MR Perfusion Imaging and Vessel Tortuosity Parameters in Assessment of Intracranial Neoplasms , 2004, Technology in cancer research & treatment.

[4]  Guido Gerig,et al.  Abnormal Vessel Tortuosity as a Marker of Treatment Response of Malignant Gliomas: Preliminary Report , 2004, Technology in cancer research & treatment.

[5]  Guido Gerig,et al.  Determining Malignancy of Brain Tumors by Analysis of Vessel Shape , 2004, MICCAI.

[6]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[7]  Guido Gerig,et al.  Automatic brain tumor segmentation by subject specific modification of atlas priors. , 2003, Academic radiology.

[8]  Glyn Johnson,et al.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.

[9]  S. Pizer,et al.  Measuring tortuosity of the intracerebral vasculature from MRA images , 2003, IEEE Transactions on Medical Imaging.

[10]  Roland Hustinx,et al.  Imaging gliomas with positron emission tomography and single-photon emission computed tomography. , 2003, Seminars in nuclear medicine.

[11]  D. Siemann.  Vascular targeting agents , 2002 .

[12]  Stephen R. Aylward,et al.  Initialization, noise, singularities, and scale in height ridge traversal for tubular object centerline extraction , 2002, IEEE Transactions on Medical Imaging.

[13]  Marc Dellian,et al.  Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  V. Tugnoli,et al.  Molecular characterization of human healthy and neoplastic cerebral and renal tissues by in vitro (1)H NMR spectroscopy (review). , 2002, International journal of molecular medicine.

[15]  Haiying Liu,et al.  A Generic Framework for Non-rigid Registration Based on Non-uniform Multi-level Free-Form Deformations , 2001, MICCAI.

[16]  Rakesh K. Jain,et al.  Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.

[17]  S. Holtås,et al.  Proton magnetic resonance spectroscopy in brain tumours: clinical applications , 2001, Neuroradiology.

[18]  M. Dewhirst,et al.  Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. , 2000, Journal of the National Cancer Institute.

[19]  J W Baish,et al.  Fractals and cancer. , 2000, Cancer research.

[20]  L. Xue,et al.  Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer. , 1999, Cancer biotherapy & radiopharmaceuticals.

[21]  Isabella M. Björkman-Burtscher.  Proton Magnetic Resonance Spectroscopy in Brain Tumors - Clinical Applications , 1999 .

[22]  Wendy S. Becker,et al.  Radioimmunoconjugates in the detection of infection and inflammation. , 1993, Seminars in nuclear medicine.

[23]  Jan J. Koenderink,et al.  Solid shape , 1990 .

[24]  B. Scheithauer,et al.  Surgical Pathology of the Nervous System and its Coverings , 1976 .

[25]  C. H. Park,et al.  Vascular structure of glioblastomas. , 1969, The American journal of roentgenology, radium therapy, and nuclear medicine.